Mar 30, 2012 Despite pressure to show uses ads and make hay from their personal data, CaringBridge refuses. They're a special case, but are there lessons here for other social networks?
Mar 28, 2012 New information from the Centers for Disease Control reveals that more than quarter of the U.S. population say they're not getting enough shuteye. The issue has consequences on our economy and health.
Mar 27, 2012 Doctor and commentator John Schumann says it's a medical urban legend.
Mar 22, 2012 Starting Monday, the Supreme Court will hear arguments on the constitutionality of the health care law, including a mandate that all Americans carry health insurance.
Mar 21, 2012 New numbers out today show that the soda sales slump that has been going on for years continued to speed up in 2011, with consumers buying more healthy beverages in its place.
Mar 16, 2012 I am a mother of five, wife to one and hold a job as a sales and marketing executive. At this time, I see it necessary to switch to a position that allows me to work more from home, without too much travel, and to build a business that I can grow into my golden years. I have started taking classes to become a Certified Financial Planner. I really want to do this, but I'm concerned my vision for being a CFP might not be viable. I would like to be fee-only and help middle-income people make sound decisions for their financial future. I have spoken with another CFP, and he has told me the focus for the industry is on high-net-worth people, which is not a path that I wish to pursue. Any advice or thoughts is most appreciated. Sarah, Rock Hall, MD
Mar 22, 2012 Publishing in the British Medical Journal, researchers looked at four studies covering 350,000 people in Asia and the West.
Mar 14, 2012 In this election year, commentator Emma Williams fears the health care program for seniors and the disabled will become a political football.
Mar 12, 2012 A new study that predicts that Americans could be spending $25 billion a year by the end of this decade on genetics testing. It's believed that the prospect of being able to sequence whole genomes at an affordable cost now is really a gamechanger.